Constellation Pharmaceuticals Inc. (CNST) NASDAQ/NGS (GLOBAL SELECT MARKET)
$33.99 - (-)
Market Cap: -
As of 07/14/21 12:00 AM EDT. Market closed.
Constellation Pharmaceuticals Inc. (CNST)
NASDAQ/NGS (GLOBAL SELECT MARKET)
$33.99
- (-)
Market Cap: -
As of 07/14/21 12:00 AM EDT. Market closed.
Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious unmet medical needs in patients with cancer. The Company has a deep understanding of how epigenetic and chromatin modifications in cancer cells and in the tumor and immune microenvironment play a fundamental role in driving disease ... read more
Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious unmet medical needs in patients with cancer. The Company has a deep understanding of how epigenetic and chromatin modifications in cancer cells and in the tumor and immune microenvironment play a fundamental role in driving disease progression and drug resistance. Constellation is driving development of the BET inhibitor CPI-0610 for the treatment of myelofibrosis as well as the EZH2 inhibitor CPI-0209 for the treatment of solid tumors. The Company is also applying its broad research and development capabilities to explore other novel targets that directly and indirectly impact gene expression to fuel a sustainable pipeline of innovative small-molecule product candidates. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO Compensation (Base)
$427,551
CEO Compensation (Total)
$4.70M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO Compensation (Base)
$427,551
CEO Compensation (Total)
$4.70M
Address
.
PRICE CHART FOR CONSTELLATION PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$34
Previous Close
$33.99
Days Range
$33.97 - $34.05
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
47,914,690
Open
$34
Previous Close
$33.99
Days Range
$33.97 - $34.05
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
47,914,690
FINANCIAL STATEMENTS FOR CONSTELLATION PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CONSTELLATION PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Reeve Emma | Chief Financial Officer | Feb 22, 2021 | Option Exercise | $8.04 | 6,260 | 50,330 | 6,260 | Feb 23, 2021, 05:58 PM |
| Reeve Emma | Chief Financial Officer | Feb 19, 2021 | Option Exercise | $8.04 | 4,010 | 32,240 | 4,010 | Feb 23, 2021, 05:58 PM |
| Reeve Emma | Chief Financial Officer | Feb 19, 2021 | Sale | $37.71 | 4,010 | 151,218 | 0 | Feb 23, 2021, 05:58 PM |
| Reeve Emma | Chief Financial Officer | Feb 22, 2021 | Sale | $37.60 | 6,260 | 235,374 | 0 | Feb 23, 2021, 05:58 PM |
| COLUMN GROUP L P | 10% Owner | Feb 17, 2021 | Sale | $36.95 | 10,000 | 369,503 | 99,155 | Feb 19, 2021, 05:32 PM |
| COLUMN GROUP L P | 10% Owner | Feb 17, 2021 | Sale | $36.95 | 10,000 | 369,503 | 99,155 | Feb 19, 2021, 05:31 PM |
| Reeve Emma | Chief Financial Officer | Feb 17, 2021 | Option Exercise | $8.04 | 410 | 3,296 | 410 | Feb 19, 2021, 04:17 PM |
| Reeve Emma | Chief Financial Officer | Feb 18, 2021 | Option Exercise | $8.04 | 1,100 | 8,844 | 1,100 | Feb 19, 2021, 04:17 PM |
| Reeve Emma | Chief Financial Officer | Feb 17, 2021 | Sale | $37.56 | 410 | 15,398 | 0 | Feb 19, 2021, 04:17 PM |
| Reeve Emma | Chief Financial Officer | Feb 18, 2021 | Sale | $37.58 | 1,100 | 41,343 | 0 | Feb 19, 2021, 04:17 PM |
| Valentine Karen | See Remarks | Jan 19, 2021 | Option Exercise | $11.50 | 17,203 | 197,835 | 17,203 | Jan 20, 2021, 05:56 PM |
| Valentine Karen | See Remarks | Jan 19, 2021 | Sale | $33.97 | 17,203 | 584,463 | 8,430 | Jan 20, 2021, 05:56 PM |
| GOLDSMITH MARK A | Director | Dec 21, 2020 | Sale | $35.02 | 4,020 | 140,769 | 139,043 | Dec 28, 2020, 04:02 PM |
| Reeve Emma | Chief Financial Officer | Dec 21, 2020 | Option Exercise | $6.81 | 5,720 | 38,975 | 5,720 | Dec 22, 2020, 04:53 PM |
| Reeve Emma | Chief Financial Officer | Dec 21, 2020 | Sale | $35.11 | 5,720 | 200,805 | 0 | Dec 22, 2020, 04:53 PM |
| COLUMN GROUP L P | 10% Owner | Dec 14, 2020 | Option Exercise | $1.55 | 30,107 | 46,666 | 2,584,957 | Dec 16, 2020, 06:42 PM |
| COLUMN GROUP L P | 10% Owner | Dec 14, 2020 | Option Exercise | $1.55 | 30,107 | 46,666 | 2,584,957 | Dec 16, 2020, 06:40 PM |
| Reeve Emma | Chief Financial Officer | Jun 08, 2020 | Option Exercise | $7.60 | 589 | 4,476 | 589 | Jun 10, 2020, 06:50 PM |
| Reeve Emma | Chief Financial Officer | Jun 08, 2020 | Sale | $37.55 | 589 | 22,118 | 377 | Jun 10, 2020, 06:50 PM |
| Audia James E | Director | May 12, 2020 | Sale | $50.10 | 6,100 | 305,622 | 25,434 | May 13, 2020, 06:30 PM |
| Senderowicz Adrian | Chief Medical Officer | May 12, 2020 | Option Exercise | $5.51 | 9,357 | 51,557 | 25,241 | May 13, 2020, 06:30 PM |
| Senderowicz Adrian | Chief Medical Officer | May 12, 2020 | Sale | $50.18 | 9,357 | 469,488 | 15,884 | May 13, 2020, 06:30 PM |
| GOLDSMITH MARK A | Director | May 12, 2020 | Option Exercise | $4.12 | 4,225 | 17,399 | 147,288 | May 13, 2020, 06:29 PM |
| GOLDSMITH MARK A | Director | May 11, 2020 | Option Exercise | $1.55 | 100 | 155 | 143,163 | May 13, 2020, 06:29 PM |
| GOLDSMITH MARK A | Director | May 12, 2020 | Sale | $50.05 | 4,225 | 211,474 | 143,063 | May 13, 2020, 06:29 PM |
| GOLDSMITH MARK A | Director | May 11, 2020 | Sale | $50.00 | 100 | 5,000 | 143,063 | May 13, 2020, 06:29 PM |
| Raythatha Jigar | See Remarks | May 12, 2020 | Option Exercise | $5.51 | 9,209 | 50,742 | 24,170 | May 13, 2020, 06:25 PM |
| Raythatha Jigar | See Remarks | May 11, 2020 | Option Exercise | $5.51 | 26 | 143 | 14,987 | May 13, 2020, 06:25 PM |
| Raythatha Jigar | See Remarks | May 11, 2020 | Sale | $50.00 | 26 | 1,300 | 14,961 | May 13, 2020, 06:25 PM |
| Raythatha Jigar | See Remarks | May 12, 2020 | Sale | $50.17 | 9,209 | 461,981 | 14,961 | May 13, 2020, 06:25 PM |
| Reeve Emma | Chief Financial Officer | May 11, 2020 | Option Exercise | $8.92 | 16,062 | 143,269 | 16,062 | May 12, 2020, 09:41 PM |
| Reeve Emma | Chief Financial Officer | May 08, 2020 | Option Exercise | $9.85 | 12,741 | 125,467 | 12,741 | May 12, 2020, 09:41 PM |
| Reeve Emma | Chief Financial Officer | May 11, 2020 | Sale | $49.53 | 16,062 | 795,623 | 0 | May 12, 2020, 09:41 PM |
| Reeve Emma | Chief Financial Officer | May 08, 2020 | Sale | $49.53 | 12,741 | 631,055 | 0 | May 12, 2020, 09:41 PM |
| Trojer Patrick | Chief Scientific Officer | May 06, 2020 | Option Exercise | $7.04 | 10,000 | 70,385 | 10,000 | May 07, 2020, 04:39 PM |
| Trojer Patrick | Chief Scientific Officer | May 06, 2020 | Sale | $45.16 | 10,000 | 451,553 | 0 | May 07, 2020, 04:39 PM |
| Valentine Karen | See Remarks | May 06, 2020 | Option Exercise | $10.96 | 12,566 | 137,749 | 12,566 | May 07, 2020, 04:34 PM |
| Valentine Karen | See Remarks | May 05, 2020 | Option Exercise | $11.50 | 4,744 | 54,556 | 4,744 | May 07, 2020, 04:34 PM |
| Valentine Karen | See Remarks | May 06, 2020 | Sale | $40.10 | 12,566 | 503,897 | 0 | May 07, 2020, 04:34 PM |
| Valentine Karen | See Remarks | May 05, 2020 | Sale | $40.01 | 4,744 | 189,817 | 0 | May 07, 2020, 04:34 PM |
| Audia James E | Director | May 06, 2020 | Sale | $45.15 | 7,500 | 338,599 | 31,534 | May 07, 2020, 04:28 PM |
| GOLDSMITH MARK A | Director | May 06, 2020 | Option Exercise | $4.26 | 11,463 | 48,825 | 154,526 | May 07, 2020, 04:25 PM |
| GOLDSMITH MARK A | Director | May 05, 2020 | Option Exercise | $3.50 | 3,145 | 11,006 | 146,208 | May 07, 2020, 04:25 PM |
| GOLDSMITH MARK A | Director | May 06, 2020 | Sale | $45.06 | 11,463 | 516,545 | 143,063 | May 07, 2020, 04:25 PM |
| GOLDSMITH MARK A | Director | May 05, 2020 | Sale | $40.01 | 3,145 | 125,824 | 143,063 | May 07, 2020, 04:25 PM |
| GOLDSMITH MARK A | Director | Apr 27, 2020 | Option Exercise | $1.55 | 400 | 620 | 143,463 | Apr 29, 2020, 08:20 PM |
| GOLDSMITH MARK A | Director | Apr 27, 2020 | Sale | $40.12 | 400 | 16,049 | 143,063 | Apr 29, 2020, 08:20 PM |
| Valentine Karen | See Remarks | Apr 27, 2020 | Option Exercise | $11.50 | 400 | 4,600 | 400 | Apr 29, 2020, 08:03 PM |
| Valentine Karen | See Remarks | Apr 27, 2020 | Sale | $40.13 | 400 | 16,052 | 0 | Apr 29, 2020, 08:03 PM |
| Valentine Karen | See Remarks | Apr 20, 2020 | Option Exercise | $11.50 | 789 | 9,074 | 789 | Apr 22, 2020, 08:17 PM |
| Valentine Karen | See Remarks | Apr 20, 2020 | Sale | $33.65 | 789 | 26,550 | 0 | Apr 22, 2020, 08:17 PM |
| Reeve Emma | Chief Financial Officer | Apr 17, 2020 | Option Exercise | $6.61 | 760 | 5,024 | 760 | Apr 20, 2020, 05:53 PM |
| Reeve Emma | Chief Financial Officer | Apr 17, 2020 | Sale | $35.29 | 760 | 26,820 | 0 | Apr 20, 2020, 05:53 PM |
| Valentine Karen | See Remarks | Apr 17, 2020 | Option Exercise | $11.50 | 2,300 | 26,450 | 2,300 | Apr 20, 2020, 05:52 PM |
| Valentine Karen | See Remarks | Apr 16, 2020 | Option Exercise | $11.50 | 2,998 | 34,477 | 2,998 | Apr 20, 2020, 05:52 PM |
| Valentine Karen | See Remarks | Apr 17, 2020 | Sale | $35.19 | 2,300 | 80,939 | 0 | Apr 20, 2020, 05:52 PM |
| Valentine Karen | See Remarks | Apr 16, 2020 | Sale | $33.57 | 2,998 | 100,637 | 1,043 | Apr 20, 2020, 05:52 PM |
| Reeve Emma | Chief Financial Officer | Apr 14, 2020 | Option Exercise | $8.76 | 1,225 | 10,731 | 1,225 | Apr 16, 2020, 02:31 PM |
| Reeve Emma | Chief Financial Officer | Apr 14, 2020 | Sale | $35.20 | 1,225 | 43,123 | 0 | Apr 16, 2020, 02:31 PM |
| Valentine Karen | See Remarks | Apr 09, 2020 | Option Exercise | $8.76 | 635 | 5,563 | 635 | Apr 13, 2020, 04:56 PM |
| Valentine Karen | See Remarks | Apr 09, 2020 | Sale | $35.02 | 635 | 22,236 | 0 | Apr 13, 2020, 04:56 PM |
| Reeve Emma | Chief Financial Officer | Apr 09, 2020 | Option Exercise | $7.78 | 700 | 5,449 | 589 | Apr 13, 2020, 04:55 PM |
| Reeve Emma | Chief Financial Officer | Apr 09, 2020 | Sale | $35.02 | 700 | 24,513 | 0 | Apr 13, 2020, 04:55 PM |
| COLUMN GROUP L P | 10% Owner | Mar 19, 2020 | Buy | $22.38 | 36,135 | 808,701 | 6,045,837 | Mar 23, 2020, 06:59 PM |
| COLUMN GROUP L P | 10% Owner | Mar 20, 2020 | Buy | $23.15 | 5,539 | 128,228 | 6,051,376 | Mar 23, 2020, 06:59 PM |
| COLUMN GROUP L P | 10% Owner | Mar 20, 2020 | Buy | $23.15 | 5,539 | 128,228 | 6,051,376 | Mar 23, 2020, 06:57 PM |
| COLUMN GROUP L P | 10% Owner | Mar 19, 2020 | Buy | $22.38 | 36,135 | 808,701 | 6,045,837 | Mar 23, 2020, 06:57 PM |
| Valentine Karen | See Remarks | Mar 09, 2020 | Option Exercise | $8.76 | 617 | 5,405 | 617 | Mar 11, 2020, 04:11 PM |
| Valentine Karen | See Remarks | Mar 09, 2020 | Sale | $32.03 | 617 | 19,763 | 465 | Mar 11, 2020, 04:11 PM |
| Reeve Emma | Chief Financial Officer | Feb 13, 2020 | Option Exercise | $8.04 | 5,521 | 44,389 | 5,521 | Feb 14, 2020, 05:09 PM |
| Reeve Emma | Chief Financial Officer | Feb 12, 2020 | Option Exercise | $8.04 | 1,103 | 8,868 | 1,103 | Feb 14, 2020, 05:09 PM |
| Reeve Emma | Chief Financial Officer | Feb 13, 2020 | Sale | $35.06 | 5,521 | 193,539 | 0 | Feb 14, 2020, 05:09 PM |
| Reeve Emma | Chief Financial Officer | Feb 12, 2020 | Sale | $35.02 | 1,103 | 38,624 | 0 | Feb 14, 2020, 05:09 PM |
| Valentine Karen | See Remarks | Feb 13, 2020 | Option Exercise | $10.33 | 4,473 | 46,217 | 4,473 | Feb 14, 2020, 05:09 PM |
| Valentine Karen | See Remarks | Feb 12, 2020 | Option Exercise | $11.50 | 1,500 | 17,250 | 1,500 | Feb 14, 2020, 05:09 PM |
| Valentine Karen | See Remarks | Feb 13, 2020 | Sale | $35.07 | 4,473 | 156,859 | 0 | Feb 14, 2020, 05:09 PM |
| Valentine Karen | See Remarks | Feb 12, 2020 | Sale | $35.02 | 1,500 | 52,527 | 0 | Feb 14, 2020, 05:09 PM |
| Valentine Karen | See Remarks | Feb 10, 2020 | Option Exercise | $11.14 | 14,096 | 157,035 | 14,096 | Feb 13, 2020, 06:22 PM |
| Valentine Karen | See Remarks | Feb 11, 2020 | Option Exercise | $11.50 | 8,550 | 98,325 | 8,550 | Feb 13, 2020, 06:22 PM |
| Valentine Karen | See Remarks | Feb 10, 2020 | Sale | $33.51 | 14,096 | 472,357 | 0 | Feb 13, 2020, 06:22 PM |
| Valentine Karen | See Remarks | Feb 11, 2020 | Sale | $35.03 | 8,550 | 299,506 | 0 | Feb 13, 2020, 06:22 PM |
| Reeve Emma | Chief Financial Officer | Feb 11, 2020 | Option Exercise | $7.67 | 8,642 | 66,308 | 7,212 | Feb 12, 2020, 05:36 PM |
| Reeve Emma | Chief Financial Officer | Feb 10, 2020 | Option Exercise | $7.60 | 200 | 1,520 | 200 | Feb 12, 2020, 05:36 PM |
| Reeve Emma | Chief Financial Officer | Feb 10, 2020 | Sale | $35.00 | 200 | 7,000 | 0 | Feb 12, 2020, 05:36 PM |
| Reeve Emma | Chief Financial Officer | Feb 11, 2020 | Sale | $35.04 | 8,642 | 302,816 | 0 | Feb 12, 2020, 05:36 PM |
| Valentine Karen | See Remarks | Feb 11, 2020 | Option Exercise | $11.50 | 8,550 | 98,325 | 8,550 | Feb 12, 2020, 05:36 PM |
| Valentine Karen | See Remarks | Feb 10, 2020 | Option Exercise | $11.50 | 14,096 | 162,104 | 14,096 | Feb 12, 2020, 05:36 PM |
| Valentine Karen | See Remarks | Feb 11, 2020 | Sale | $35.03 | 8,550 | 299,506 | 0 | Feb 12, 2020, 05:36 PM |
| Valentine Karen | See Remarks | Feb 10, 2020 | Sale | $33.51 | 14,096 | 472,357 | 0 | Feb 12, 2020, 05:36 PM |
| EVNIN ANTHONY B | Director | Dec 13, 2019 | Buy | $34.50 | 400,000 | 13,800,000 | 5,742,765 | Dec 16, 2019, 05:57 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Dec 13, 2019 | Buy | $34.50 | 400,000 | 13,800,000 | 4,016,873 | Dec 16, 2019, 05:56 PM |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 10% Owner | Nov 08, 2019 | Sale | $30.33 | 174,316 | 5,287,179 | 2,197,406 | Nov 13, 2019, 08:31 PM |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 10% Owner | Nov 12, 2019 | Sale | $32.77 | 12,800 | 419,456 | 2,110,290 | Nov 13, 2019, 08:31 PM |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 10% Owner | Nov 12, 2019 | Sale | $32.77 | 12,800 | 419,456 | 2,111,290 | Nov 12, 2019, 09:19 PM |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 10% Owner | Nov 08, 2019 | Sale | $30.26 | 1,074,316 | 32,512,179 | 2,197,406 | Nov 12, 2019, 09:19 PM |
| Senderowicz Adrian | Chief Medical Officer | Nov 06, 2019 | Option Exercise | $5.51 | 27,232 | 150,048 | 43,116 | Nov 08, 2019, 05:28 PM |
| Senderowicz Adrian | Chief Medical Officer | Nov 06, 2019 | Sale | $28.12 | 27,232 | 765,849 | 37,685 | Nov 08, 2019, 05:28 PM |
| Reeve Emma | Chief Financial Officer | Nov 06, 2019 | Option Exercise | $6.75 | 65,626 | 442,781 | 65,626 | Nov 08, 2019, 05:01 PM |
| Reeve Emma | Chief Financial Officer | Nov 06, 2019 | Sale | $21.50 | 65,626 | 1,410,775 | 63,052 | Nov 08, 2019, 05:01 PM |
| Trojer Patrick | Chief Scientific Officer | Nov 06, 2019 | Option Exercise | $6.12 | 37,920 | 231,890 | 46,142 | Nov 08, 2019, 05:01 PM |
| Trojer Patrick | Chief Scientific Officer | Nov 06, 2019 | Sale | $25.07 | 46,142 | 1,156,854 | 34,607 | Nov 08, 2019, 05:01 PM |
| Audia James E | Director | Nov 06, 2019 | Sale | $18.55 | 22,500 | 417,411 | 57,034 | Nov 08, 2019, 05:00 PM |
| Raythatha Jigar | See Remarks | Nov 06, 2019 | Option Exercise | $5.51 | 102,750 | 566,153 | 117,711 | Nov 08, 2019, 05:00 PM |
| Raythatha Jigar | See Remarks | Nov 06, 2019 | Sale | $28.33 | 102,750 | 2,911,381 | 100,331 | Nov 08, 2019, 05:00 PM |
| Reeve Emma | Chief Financial Officer | Nov 05, 2019 | Option Exercise | $6.61 | 1,000 | 6,610 | 1,000 | Nov 07, 2019, 04:44 PM |
| Reeve Emma | Chief Financial Officer | Nov 05, 2019 | Sale | $15.50 | 1,000 | 15,504 | 0 | Nov 07, 2019, 04:44 PM |
| Audia James E | Director | Nov 05, 2019 | Sale | $15.01 | 2,288 | 34,351 | 61,534 | Nov 06, 2019, 04:26 PM |
| Trojer Patrick | Chief Scientific Officer | Nov 05, 2019 | Option Exercise | $5.51 | 1,150 | 6,337 | 9,372 | Nov 06, 2019, 04:26 PM |
| Trojer Patrick | Chief Scientific Officer | Nov 04, 2019 | Option Exercise | $5.51 | 100 | 551 | 8,322 | Nov 06, 2019, 04:26 PM |
| Trojer Patrick | Chief Scientific Officer | Nov 05, 2019 | Sale | $15.01 | 1,150 | 17,256 | 8,222 | Nov 06, 2019, 04:26 PM |
| Trojer Patrick | Chief Scientific Officer | Nov 04, 2019 | Sale | $15.00 | 100 | 1,500 | 8,222 | Nov 06, 2019, 04:26 PM |
| Trojer Patrick | Chief Scientific Officer | Oct 23, 2019 | Option Exercise | $5.51 | 300 | 1,653 | 8,522 | Oct 24, 2019, 03:45 PM |
| Trojer Patrick | Chief Scientific Officer | Oct 22, 2019 | Option Exercise | $5.29 | 7,930 | 41,977 | 18,207 | Oct 24, 2019, 03:45 PM |
| Trojer Patrick | Chief Scientific Officer | Oct 23, 2019 | Sale | $15.20 | 300 | 4,559 | 8,222 | Oct 24, 2019, 03:45 PM |
| Trojer Patrick | Chief Scientific Officer | Oct 22, 2019 | Sale | $15.00 | 9,985 | 149,802 | 8,222 | Oct 24, 2019, 03:45 PM |
| Audia James E | Director | Oct 23, 2019 | Sale | $15.15 | 200 | 3,029 | 63,822 | Oct 24, 2019, 03:44 PM |
| Audia James E | Director | Oct 22, 2019 | Sale | $15.01 | 5,012 | 75,213 | 64,022 | Oct 24, 2019, 03:44 PM |
| COLUMN GROUP L P | 10% Owner | Oct 03, 2019 | Buy | $8.50 | 1,331,764 | 11,319,994 | 6,009,702 | Oct 07, 2019, 05:35 PM |
| COLUMN GROUP L P | 10% Owner | Oct 03, 2019 | Buy | $8.50 | 80,000 | 680,000 | 159,155 | Oct 07, 2019, 05:35 PM |
| EVNIN ANTHONY B | Director | Oct 03, 2019 | Buy | $8.50 | 2,823,529 | 23,999,997 | 5,342,765 | Oct 04, 2019, 05:33 PM |
| Senderowicz Adrian | Chief Medical Officer | Dec 13, 2018 | Option Exercise | $5.51 | 15,884 | 87,521 | 15,884 | Dec 17, 2018, 04:46 PM |
| TEPPER ROBERT I | Director | Aug 22, 2018 | Option Exercise | $1.55 | 51,032 | 79,100 | 3,034,083 | Aug 24, 2018, 04:05 PM |
| THIRD ROCK VENTURES LP | 10% Owner | Aug 22, 2018 | Option Exercise | $1.55 | 51,032 | 79,100 | 3,034,083 | Aug 24, 2018, 04:05 PM |
| THIRD ROCK VENTURES LP | 10% Owner | Jul 23, 2018 | Buy | $15.00 | 266,667 | 4,000,005 | 2,983,051 | Jul 24, 2018, 07:19 PM |
| TEPPER ROBERT I | Director | Jul 23, 2018 | Buy | $15.00 | 266,667 | 4,000,005 | 2,983,051 | Jul 24, 2018, 07:15 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jul 23, 2018 | Buy | $15.00 | 200,000 | 3,000,000 | 417,921 | Jul 24, 2018, 04:46 PM |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 10% Owner | Jul 23, 2018 | Buy | $15.00 | 133,333 | 1,999,995 | 2,297,406 | Jul 23, 2018, 08:15 PM |
| Casdin Capital, LLC | 10% Owner | Jul 23, 2018 | Buy | $15.00 | 266,667 | 4,000,005 | 612,450 | Jul 23, 2018, 08:12 PM |
| EVNIN ANTHONY B | Director | Jul 23, 2018 | Buy | $15.00 | 133,334 | 2,000,010 | 2,519,236 | Jul 23, 2018, 08:04 PM |
| Alexandria Venture Investments, LLC | 10% Owner | Jul 23, 2018 | Buy | $15.00 | 66,667 | 1,000,005 | 216,304 | Jul 23, 2018, 04:54 PM |
| Flynn James E | 10% Owner | Jul 23, 2018 | Buy | $15.00 | 200,000 | 3,000,000 | 835,843 | Jul 23, 2018, 01:00 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Reeve Emma | Chief Financial Officer | 02/22/2021 | 50,330 |
| Reeve Emma | Chief Financial Officer | 02/19/2021 | 32,240 |
| Reeve Emma | Chief Financial Officer | 02/19/2021 | 151,218 |
| Reeve Emma | Chief Financial Officer | 02/22/2021 | 235,374 |
| COLUMN GROUP L P | 10% Owner | 02/17/2021 | 369,503 |
| COLUMN GROUP L P | 10% Owner | 02/17/2021 | 369,503 |
| Reeve Emma | Chief Financial Officer | 02/17/2021 | 3,296 |
| Reeve Emma | Chief Financial Officer | 02/18/2021 | 8,844 |
| Reeve Emma | Chief Financial Officer | 02/17/2021 | 15,398 |
| Reeve Emma | Chief Financial Officer | 02/18/2021 | 41,343 |
| Valentine Karen | See Remarks | 01/19/2021 | 197,835 |
| Valentine Karen | See Remarks | 01/19/2021 | 584,463 |
| GOLDSMITH MARK A | Director | 12/21/2020 | 140,769 |
| Reeve Emma | Chief Financial Officer | 12/21/2020 | 38,975 |
| Reeve Emma | Chief Financial Officer | 12/21/2020 | 200,805 |
| COLUMN GROUP L P | 10% Owner | 12/14/2020 | 46,666 |
| COLUMN GROUP L P | 10% Owner | 12/14/2020 | 46,666 |
| Reeve Emma | Chief Financial Officer | 06/08/2020 | 4,476 |
| Reeve Emma | Chief Financial Officer | 06/08/2020 | 22,118 |
| Audia James E | Director | 05/12/2020 | 305,622 |
| Senderowicz Adrian | Chief Medical Officer | 05/12/2020 | 51,557 |
| Senderowicz Adrian | Chief Medical Officer | 05/12/2020 | 469,488 |
| GOLDSMITH MARK A | Director | 05/12/2020 | 17,399 |
| GOLDSMITH MARK A | Director | 05/11/2020 | 155 |
| GOLDSMITH MARK A | Director | 05/12/2020 | 211,474 |
| GOLDSMITH MARK A | Director | 05/11/2020 | 5,000 |
| Raythatha Jigar | See Remarks | 05/12/2020 | 50,742 |
| Raythatha Jigar | See Remarks | 05/11/2020 | 143 |
| Raythatha Jigar | See Remarks | 05/11/2020 | 1,300 |
| Raythatha Jigar | See Remarks | 05/12/2020 | 461,981 |
| Reeve Emma | Chief Financial Officer | 05/11/2020 | 143,269 |
| Reeve Emma | Chief Financial Officer | 05/08/2020 | 125,467 |
| Reeve Emma | Chief Financial Officer | 05/11/2020 | 795,623 |
| Reeve Emma | Chief Financial Officer | 05/08/2020 | 631,055 |
| Trojer Patrick | Chief Scientific Officer | 05/06/2020 | 70,385 |
| Trojer Patrick | Chief Scientific Officer | 05/06/2020 | 451,553 |
| Valentine Karen | See Remarks | 05/06/2020 | 137,749 |
| Valentine Karen | See Remarks | 05/05/2020 | 54,556 |
| Valentine Karen | See Remarks | 05/06/2020 | 503,897 |
| Valentine Karen | See Remarks | 05/05/2020 | 189,817 |
| Audia James E | Director | 05/06/2020 | 338,599 |
| GOLDSMITH MARK A | Director | 05/06/2020 | 48,825 |
| GOLDSMITH MARK A | Director | 05/05/2020 | 11,006 |
| GOLDSMITH MARK A | Director | 05/06/2020 | 516,545 |
| GOLDSMITH MARK A | Director | 05/05/2020 | 125,824 |
| GOLDSMITH MARK A | Director | 04/27/2020 | 620 |
| GOLDSMITH MARK A | Director | 04/27/2020 | 16,049 |
| Valentine Karen | See Remarks | 04/27/2020 | 4,600 |
| Valentine Karen | See Remarks | 04/27/2020 | 16,052 |
| Valentine Karen | See Remarks | 04/20/2020 | 9,074 |
| Valentine Karen | See Remarks | 04/20/2020 | 26,550 |
| Reeve Emma | Chief Financial Officer | 04/17/2020 | 5,024 |
| Reeve Emma | Chief Financial Officer | 04/17/2020 | 26,820 |
| Valentine Karen | See Remarks | 04/17/2020 | 26,450 |
| Valentine Karen | See Remarks | 04/16/2020 | 34,477 |
| Valentine Karen | See Remarks | 04/17/2020 | 80,939 |
| Valentine Karen | See Remarks | 04/16/2020 | 100,637 |
| Reeve Emma | Chief Financial Officer | 04/14/2020 | 10,731 |
| Reeve Emma | Chief Financial Officer | 04/14/2020 | 43,123 |
| Valentine Karen | See Remarks | 04/09/2020 | 5,563 |
| Valentine Karen | See Remarks | 04/09/2020 | 22,236 |
| Reeve Emma | Chief Financial Officer | 04/09/2020 | 5,449 |
| Reeve Emma | Chief Financial Officer | 04/09/2020 | 24,513 |
| COLUMN GROUP L P | 10% Owner | 03/19/2020 | 808,701 |
| COLUMN GROUP L P | 10% Owner | 03/20/2020 | 128,228 |
| COLUMN GROUP L P | 10% Owner | 03/20/2020 | 128,228 |
| COLUMN GROUP L P | 10% Owner | 03/19/2020 | 808,701 |
| Valentine Karen | See Remarks | 03/09/2020 | 5,405 |
| Valentine Karen | See Remarks | 03/09/2020 | 19,763 |
| Reeve Emma | Chief Financial Officer | 02/13/2020 | 44,389 |
| Reeve Emma | Chief Financial Officer | 02/12/2020 | 8,868 |
| Reeve Emma | Chief Financial Officer | 02/13/2020 | 193,539 |
| Reeve Emma | Chief Financial Officer | 02/12/2020 | 38,624 |
| Valentine Karen | See Remarks | 02/13/2020 | 46,217 |
| Valentine Karen | See Remarks | 02/12/2020 | 17,250 |
| Valentine Karen | See Remarks | 02/13/2020 | 156,859 |
| Valentine Karen | See Remarks | 02/12/2020 | 52,527 |
| Valentine Karen | See Remarks | 02/10/2020 | 157,035 |
| Valentine Karen | See Remarks | 02/11/2020 | 98,325 |
| Valentine Karen | See Remarks | 02/10/2020 | 472,357 |
| Valentine Karen | See Remarks | 02/11/2020 | 299,506 |
| Reeve Emma | Chief Financial Officer | 02/11/2020 | 66,308 |
| Reeve Emma | Chief Financial Officer | 02/10/2020 | 1,520 |
| Reeve Emma | Chief Financial Officer | 02/10/2020 | 7,000 |
| Reeve Emma | Chief Financial Officer | 02/11/2020 | 302,816 |
| Valentine Karen | See Remarks | 02/11/2020 | 98,325 |
| Valentine Karen | See Remarks | 02/10/2020 | 162,104 |
| Valentine Karen | See Remarks | 02/11/2020 | 299,506 |
| Valentine Karen | See Remarks | 02/10/2020 | 472,357 |
| EVNIN ANTHONY B | Director | 12/13/2019 | 13,800,000 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 12/13/2019 | 13,800,000 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 10% Owner | 11/08/2019 | 5,287,179 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 10% Owner | 11/12/2019 | 419,456 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 10% Owner | 11/12/2019 | 419,456 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 10% Owner | 11/08/2019 | 32,512,179 |
| Senderowicz Adrian | Chief Medical Officer | 11/06/2019 | 150,048 |
| Senderowicz Adrian | Chief Medical Officer | 11/06/2019 | 765,849 |
| Reeve Emma | Chief Financial Officer | 11/06/2019 | 442,781 |
| Reeve Emma | Chief Financial Officer | 11/06/2019 | 1,410,775 |
| Trojer Patrick | Chief Scientific Officer | 11/06/2019 | 231,890 |
| Trojer Patrick | Chief Scientific Officer | 11/06/2019 | 1,156,854 |
| Audia James E | Director | 11/06/2019 | 417,411 |
| Raythatha Jigar | See Remarks | 11/06/2019 | 566,153 |
| Raythatha Jigar | See Remarks | 11/06/2019 | 2,911,381 |
| Reeve Emma | Chief Financial Officer | 11/05/2019 | 6,610 |
| Reeve Emma | Chief Financial Officer | 11/05/2019 | 15,504 |
| Audia James E | Director | 11/05/2019 | 34,351 |
| Trojer Patrick | Chief Scientific Officer | 11/05/2019 | 6,337 |
| Trojer Patrick | Chief Scientific Officer | 11/04/2019 | 551 |
| Trojer Patrick | Chief Scientific Officer | 11/05/2019 | 17,256 |
| Trojer Patrick | Chief Scientific Officer | 11/04/2019 | 1,500 |
| Trojer Patrick | Chief Scientific Officer | 10/23/2019 | 1,653 |
| Trojer Patrick | Chief Scientific Officer | 10/22/2019 | 41,977 |
| Trojer Patrick | Chief Scientific Officer | 10/23/2019 | 4,559 |
| Trojer Patrick | Chief Scientific Officer | 10/22/2019 | 149,802 |
| Audia James E | Director | 10/23/2019 | 3,029 |
| Audia James E | Director | 10/22/2019 | 75,213 |
| COLUMN GROUP L P | 10% Owner | 10/03/2019 | 11,319,994 |
| COLUMN GROUP L P | 10% Owner | 10/03/2019 | 680,000 |
| EVNIN ANTHONY B | Director | 10/03/2019 | 23,999,997 |
| Senderowicz Adrian | Chief Medical Officer | 12/13/2018 | 87,521 |
| TEPPER ROBERT I | Director | 08/22/2018 | 79,100 |
| THIRD ROCK VENTURES LP | 10% Owner | 08/22/2018 | 79,100 |
| THIRD ROCK VENTURES LP | 10% Owner | 07/23/2018 | 4,000,005 |
| TEPPER ROBERT I | Director | 07/23/2018 | 4,000,005 |
| ORBIMED ADVISORS LLC | 10% Owner | 07/23/2018 | 3,000,000 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 10% Owner | 07/23/2018 | 1,999,995 |
| Casdin Capital, LLC | 10% Owner | 07/23/2018 | 4,000,005 |
| EVNIN ANTHONY B | Director | 07/23/2018 | 2,000,010 |
| Alexandria Venture Investments, LLC | 10% Owner | 07/23/2018 | 1,000,005 |
| Flynn James E | 10% Owner | 07/23/2018 | 3,000,000 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR CONSTELLATION PHARMACEUTICALS INC
LOADING...